169333 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
Method of Determining Risk for Chronic Stress and Stroke
#2PROGNOSTIC AND DIAGNOSTIC METHODS FOR RISK OF ACUTE KIDNEY INJURY
#3MASS SPECTROMETRIC ANALYSIS OF BIOMARKERS
#4PRESCRIPTION OF REMOTE PATIENT MANAGEMENT BASED ON BIOMARKERS
#5METHOD FOR TESTING TERTIARY LYMPHOID TISSUE, AND KIT FOR TESTING TERTIARY LYMPHOID TISSUE
#6USE OF MYOSTATIN INHIBITOR FOR TREATING SPINAL MUSCULAR ATROPHY
#7BIOMARKER COMPOSITION FOR EARLY DIAGNOSIS OF KIDNEY DISEASES, AND METHOD FOR PROVIDING INFORMATION REQUIRED FOR EARLY DIAGNOSIS OF KIDNEY DISEASES BY USING SAME
#8NUCLEIC ACID SEQUENCES RESPONSIVE TO CREATININE IN CLINICALLY USEFUL RANGES
#9Methods for Detecting Renal Disease
#10MICROFLUIDIC URINE ALBUMIN/CREATININE CHIP (uACR-CHIP) FOR CHRONIC KIDNEY DISEASE EVALUATION
#11CREATININE LATERAL FLOW ASSAY DEVICES AND METHODS OF PRODUCTION AND USE THEREOF
#12MINIATURIZED HANDHELD ELECTROCHEMICAL-BIOSENSOR SYSTEM FOR DETECTING CREATININE FROM SERUM SAMPLES AND ITS METHOD THEREOF
#13DETECTION AND QUANTITATION OF GUANIDINOACETATE, CREATINE, AND CREATININE BY MASS SPECTROMETRY
#14NONINVASIVE METHOD TO QUANTIFY KIDNEY FUNCTION AND FUNCTIONAL DECLINE
#15DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS
#16DETECTING THE PRESENCE OF URINARY STONE DISEASE USING A PLURALITY OF URINARY METABOLITES
#17BLOOD SEPARATION AND ANALYSIS DEVICE AND METHODS
#18A DEVICE FOR AN AUTOMATED DETERMINATION OF AN ANALYTE IN LIQUID PHASE AND A METHOD FOR AN AUTOMATED DETERMINATION OF AN ANAL YTE IN LIQUID PHASE USING THE DEVICE, IN PARTICULAR FOR MONITORING A PROGRESS OF A DIALYSIS
#19ANALYTE DETERMINATION METHOD AND SENSING ASSEMBLY
#20METHODS FOR DETERMINING AND/OR MONITORING THE HEALTH STATUS OF FISH
#21Method for Using a Marker Set for Determining the Risk of Kidney Rejection
#22DEVICES, SYSTEMS, AND METHODS FOR MEASURING BIOMARKERS IN BIOLOGICAL FLUIDS
#23Urinary Metabolites as Predictors of Acute Mountain Sickness Severity
#24METHOD OF DIAGNOSING AND TREATING CHRONIC KIDNEY DISEASE
#25NOVEL IMMUNOPROBE-BASED METHOD TO ASSESS ORGAN INJURY STATUS THROUGH A BIOFLUID-BASED CELL-FREE DNA (CFDNA) ASSAY
#26METHOD FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER, SYSTEM FOR PROVIDING INFORMATION RELATED TO TYPE OF CANCER
#27PAPER-BASED DEVICE AND USES THEREOF FOR MONITORING RECURRENCE OF CANCERS
#28METHOD FOR EXAMINING PROGRESSION OF CHRONIC KIDNEY DISEASE IN SUBJECT, AND KIT
#29METHOD FOR DETERMINING PROSTATE CANCER
#30SFLT1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#31METHOD FOR CALIBRATING A DEVICE FOR MEASURING THE CONCENTRATION OF CREATININE
#32PCT MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#33INFORMATION PROCESSING DEVICE FOR PROVIDING REFERENCE INFORMATION RELATING TO DIAGNOSIS OF THYROID DISEASE
#34IL6 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#35Detection and quantitation of guanidinoacetate, creatine, and creatinine by mass spectrometry
#36PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY
#37METHOD FOR ASSESSING MITOCHONDRIAL FUNCTION IN TISSUE OR ORGAN OTHER THAN KIDNEY IN TEST SUBJECT
#38Methods and Systems for Determining Autism Spectrum Disorder Risk
#39Creatinine Assay Kit with Desirable Stability and Capable of Rapidly Eliminating Drug Interference
#40PROTOCOL TO MINIMIZE CALCINEURIN INHIBITOR NEPHROTOXICITY
#41BIOMARKER TEST WITH UNIFIED PIGMENTATION
#42A Home Test for Measuring Glucose Control and Kidney Function in Patients
#43INTEGRATING RESULTS OF IMAGE-BASED ANALYSIS WITH ELECTRONIC MEDICAL RECORDS
#44ADENOCARCINOMA DETECTION METHOD, AND EXAMINATION KIT
#45Devices, systems, and methods for measuring biomarkers in biological fluids
#46BIOMETRIC SYSTEM
#47CELL-FREE BIOSENSORS TO DETECT CREATININE, CREATINE, AND SARCOSINE
#48C5aR INHIBITOR REDUCTION OF URINARY sCD163
#49Noninvasive method to quantify kidney function and functional decline
#50Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#51METHOD FOR CREATING A RENAL INJURY MODEL TO SCREEN MOLECULES FOR THE TREATMENT OF RENAL INJURY
#52Coupon design for enhanced color sensitivity for colorimetric-based chemical analysis of liquids
#53HEART FAILURE MARKER
#54Methods of preparing a biofluid sample for detection of kidney injury
#55MASS SPECTROMETRIC ANALYSIS OF BIOMARKERS
#56URINALYSIS TEST STRIP FOR OVER-THE-COUNTER USE
#57PRESCRIPTION OF REMOTE PATIENT MANAGEMENT BASED ON BIOMARKERS
#58SYSTEMS AND METHODS FOR DETECTION OF CHEMILUMINESCENT REACTIONS
#59Concurrent analysis of multiple analytes
#60MULTI-ENZYMATIC BIOSENSORS AND STABILIZATION OF MULTI-ENZYMATIC BIOSENSORS AT ROOM TEMPERATURE
#61DISCOVERY AND VALIDATION OF AN EARLY POST-TRANSPLANT BIOMARKER PREDICTIVE OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS
#62PROGNOSTIC AND DIAGNOSTIC METHODS FOR RISK OF ACUTE KIDNEY INJURY
#63METHOD FOR ASSISTING EVALUATION OF RENAL PATHOLOGICAL CONDITIONS, SYSTEM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS AND PROGRAM FOR EVALUATING RENAL PATHOLOGICAL CONDITIONS
#64BIOSENSOR FOR DETECTION OF ANALYTES IN A FLUID
#65BIOCIDE COMPOSITIONS COMPATIBLE WITH ENZYME BIOSENSORS AND METHODS OF USE THEREOF
#66METHOD FOR EVALUATING SAMPLE, ANALYSIS METHOD, METHOD FOR DETECTING DEGRADED SAMPLE, MARKER FOR DETECTING DEGRADED BLOOD PLASMA SAMPLE, AND MARKER FOR DETECTING DEGRADED SERUM SAMPLE
#67Methods for Detecting Renal Disease
#68Method for calibrating a device for measuring the concentration of creatinine
#69METHODS FOR TREATING DILATED CARDIOMYOPATHY
#70Blood separation and analysis device and methods
#71Blood separation and analysis device and methods
#72Reagents for detecting Alu elements in cell-free DNA (cfDNA)
#73Tracking wound healing progress using remote image analysis
#74Noninvasive method to quantify kidney function and functional decline
#75MARKER FOR DETERMING CRITICAL STAGE KIDNEY DISEASE
#76Coupon design for enhanced color sensitivity for colorimetric-based chemical analysis of liquids
#77Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay
#78Biomarkers for Precisely Predicting the Glomerular Filtration Rate and for Indicating Pathophysiologic Factors of an Impaired Glomerular Filtration Rate
#79Passive mixing microfluidic urinary albumin chip (UAL-chip) for chronic kidney disease
#80Microalbumin creatinine assay detection flag and methods of production and use related thereto
#81BIOMARKERS AND CLASSIFICATION ALGORITHMS FOR CHRONIC KIDNEY DISEASE IN CATS
#82Devices, systems, and methods for measuring biomarkers in biological fluids
#83Methods and Kits for Detection of 11-dehydro-thromboxane B2
#84NMR SYSTEMS AND METHODS FOR THE RAPID DETECTION OF ANALYTES
#85Urine sample testing apparatus and apparatus for processing measurement results of urine sample
#86Biocide compositions compatible with enzyme biosensors and methods of use thereof
#87Ambrisentan for use in the treatment of acute renal failure
#88Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay
#89DETECTION OF CREATINE LEVELS USING ENZYME COMPOSITIONS
#90METHODS OF DIAGNOSING AND TREATING PARTICULAR CAUSAL COMPONENTS OF CHRONIC PAIN IN A PATIENT
#91MODIFICATION TO STAGING GUIDELINES FOR IMPROVED ACUTE KIDNEY INJURY (AKI) RECOVERY DETECTION
#92Compositions and methods for improved creatinine measurement accuracy and uses thereof
#93COMPOSITIONS AND METHODS FOR IMPROVED CALIBRATION ACCURACY OF CREATININE/CREATINE SENSORS AND USES THEREOF
#94Outer membrane compositions for creatinine/creatine sensors
#95Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature
#96Urea biosensors and stabilization of urea biosensors at room temperature
#97Means for the quantitative determination of sodium concentration and creatinine concentration
#98Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#99Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#100BIOMARKERS FOR PREDICTING PROGNOSIS OF KIDNEY DISEASE
#101MARKER FOR HEALTH ASSESSMENT, AND APPLICATION THEREOF
#102Levels, functions, and resistances related to chronic conditions by using lysine-based supplements
#103Analyte Sensors and Sensing Methods for Detecting Creatinine
#104Home testing data automatically changes insurance status
#105UPDATING AN ELECTRONIC MEDICAL RECORD BASED ON PATIENT GENERATED IMAGE DATA
#106Uniquely coded color boards for analyzing images
#107Tracking wound healing progress using remote image analysis
#108IMPROVED LIQUID TEST SAMPLE DISPENSING DEVICE FOR THE COLLECTION OF LIQUID WASTE AND METHODS OF USE RELATED THERETO
#109MARKERS IN PREPUBERTY FOR CHILDHOOD-PREDIABETES
#110METHOD AND APPARATUS FOR DETERMINING INTERSTITIAL VOLUME
#111Biometric system
#112METHODS FOR ASSESSING GRAFT FAILURE RISK
#113METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE
#114Risk Assessment Tool for Patients with Sepsis
#115Salivary urea nitrogen rapid detection
#116Urinalysis device and test strip for home and point of care use
#117DISCOVERY AND VALIDATION OF AN EARLY POST-TRANSPLANT BIOMARKER PREDICTIVE OF CHRONIC KIDNEY DISEASE IN LIVER TRANSPLANT RECIPIENTS
#118BIOMARKERS RELATED TO KIDNEY FUNCTION AND METHODS USING THE SAME
#119Simultaneous measurement of multiple analytes of a liquid assay
#120Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (cfDNA) assay
#121METHOD FOR CALCULATING GLOMERULAR FILTRATION RATE (GFR)
#122Method for Using a Marker Set for Determining the Risk of Kidney Rejection
#123Method for creating a renal injury model to screen molecules for the treatment of renal injury
#124Bag containing a reference fluid
#125Mass spectrometry assay method for detection and quantitation of kidney function metabolites
#126Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#127METHODS FOR THE USE OF GALECTIN 3 BINDING PROTEIN DETECTED IN THE URINE FOR MONITORING THE SEVERITY AND PROGRESSION OF LUPUS NEPHRITIS
#128DETERMINATION METHOD AND SYSTEM THEREOF
#129Modified sarcosine oxidase, and gene and production method therefor
#130Immunoprobe-based method to assess organ injury status through a biofluid-based cell-free DNA (CFDNA) assay
#131Urinalysis device and dry reagent for quantitative urinalysis
#132Urinalysis device and dry reagent for quantitative urinalysis
#133Compositions and methods for treating and preventing end stage renal disease
#134Detection and quantitation of guanidinoacetate, creatine, and creatinine by mass spectrometry
#135DETECTING CHRONIC BLOOD AND NEPHROLOGICAL DISORDERS IN A BIO-SAMPLE USING SPECTRAL ANALYSIS
#136INHIBITING CHRONIC BLOOD AND NEPHROLOGICAL DISORDERS USING LYSINE-BASED SUPPLEMENTS
#137Inhibiting chronic blood and nephrological disorders using lysine-based supplements
#138Inhibiting chronic blood and nephrological disorders using lysine-based supplements
#139C5aR INHIBITOR REDUCTION OF URINARY sCD163
#140NMR SYSTEMS AND METHODS FOR THE RAPID DETECTION OF ANALYTES
#141Ambrisentan for use in the treatment of acute renal failure
#142Methods of treating volume depletion and kidney injury
#143METHODS FOR DETERMINING TOTAL BODY SKELETAL MUSCLE MASS
#144SYSTEMS AND METHODS FOR MONITORING AN INDIVIDUAL'S HEALTH
#145METHOD AND DEVICE FOR MONITORING MEDICATION USAGE
#146METHOD TO DETECT BLOOD CREATININE AND AN IMMUNOSUPPRESSIVE DRUG
#147Method of Determining Risk of an Adverse Cardiac Event
#148Method for correcting Crea sensor for calcium inhibition
#149Test device and method of operating the same
#150Device and method for detecting creatinine and albumin to creatinine ratio
#151METHOD FOR SCREENING DIABETIC NEPHROPATHY IN A SUBJECT
#152Method and apparatus for determining a patient's filtration rate
#153Systems and methods for detection of chemtiluminescent reactions
#154METHODS AND SYSTEMS FOR DIAGNOSING SLEEP DISORDERS
#155Calixpyrrole compounds and creatinine-selective electrodes comprising them
#156METHODS FOR DETERMINING TOTAL BODY SKELETAL MUSCLE MASS
#157Calibration concept for amperometric creatinine sensor correcting for endogenous modulators
#158METHOD FOR CALIBRATING A DEVICE FOR MEASURING THE CONCENTRATION OF CREATININE
#159Method for calibrating a device for measuring the concentration of creatinine
#160Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#161METHODS OF MONITORING FOR ADHERENCE TO ARIPIPRAZOLE THERAPY
#162METHODS OF MONITORING FOR ADHERENCE TO BREXPIPRAZOLE (REXULTI®) THERAPY
#163NMR SYSTEMS AND METHODS FOR THE RAPID DETECTION OF ANALYTES
#164Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#165SYSTEMS AND METHODS FOR QUANTIFICATION OF CREATININE USING A CREATININE-PROTEIN CONJUGATE
#166Bag containing a reference fluid
#167PREDICTING RAPID DECLINE IN RENAL FUNCTION IN DIABETES
#168In vitro diagnostic and prognosis of major adverse events in patients undergoing coronary angiography
#169Urinalysis device and dry reagent for quantitative urinalysis
#170Prediction of acute kidney injury from a post-surgical metabolic blood panel
#171Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides
#172Method and Device for Monitoring Medication Usage
#173SYSTEMS AND METHODS FOR MULTI-ANALYSIS
#174Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#175Methods for determining total body skeletal muscle mass
#176Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#177Methods for detecting renal disease
#178METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#179METHODS FOR DETERMINING TOTAL BODY SKELETAL MUSCLE MASS
#180Biomarkers related to kidney function and methods using the same
#181Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#182Urea-based synthetic urine and method of manufacturing same
#183Artemisinin and its derivatives for use in the treatment of kidney disease
#184ACUTE KIDNEY INJURY
#185Methods and systems for determining autism spectrum disorder risk
#186Kidney disease biomarker
#187ADMINISTRATION OF AN ANTI-OBESITY COMPOUND TO INDIVIDUALS WITH RENAL IMPAIRMENT
#188POLYMER MATRIX WITH TARGET BINDING SITE FOR CREATININE AND DERIVATIVES THEREOF, ITS PREPARATION AND USES
#189Device and method for bilirubin photoisomerization to reduce laboratory test interference
#190PRENATAL SCREENING FOR DOWN SYNDROME AND TRISOMY 18
#191Diagnostic agent for tumor
#192MEANS AND METHODS FOR ASSESSING HYPERTHYROIDISM
#193Method and Device for Monitoring Medication Usage
#194MEANS AND METHODS FOR ASSESSING KIDNEY TOXICITY
#195METHODS FOR DETERMINING TOTAL BODY SKELETAL MUSCLE MASS
#196Urea-based synthetic urine and method of manufacturing same
#197Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#198Methods of monitoring for adherence to aripiprazole therapy
#199Rapid test for urine albumin and urine creatinine
#200Markers for acute kidney injury
#201METHOD OF DIAGNOSING TRICHOTILLOMANIA AND SIMILAR DISORDERS IN HUMANS AND RODENTS
#202Dry test strip and method for measuring creatinine
#203Method of Treatment and Screening Method
#204Administration of an anti-obesity compound to individuals with renal impairment
#205Urine sample testing apparatus and apparatus for processing measurement result of urine sample
#206Blood component measurement method utilizing hemolyzed whole blood, and kit for the method
#207METHOD, DEVICE AND APPARATUS FOR MEASURING THE CONCENTRATION OF CREATININE, AND METHOD, DEVICE AND APPARATUS FOR MEASURING THE AMOUNT OF SALT IN URINE USING THE SAME
#208METHOD AND DEVICE FOR MONITORING MEDICATION USAGE
#209DIAGNOSTIC DEVICE FOR IDENTIFYING RUPTURE OF MEMBRANE DURING PREGNANCY
#210METHOD, DEVICE AND APPARATUS FOR MEASURING THE CONCENTRATION OF CREATININE, AND METHOD, DEVICE AND APPARATUS FOR MEASURING THE AMOUNT OF SALT USING THE SAME
#211Method, device and apparatus for measuring the concentration of creatinine, and method, device and apparatus for measuring the amount of salt using the same
#212Renal monitor
#213Method, device and apparatus for measuring the concentration of creatinine, and method, device and apparatus for measuring the amount of salt in urine using the same
#214IL-8 AS BIOMARKER FOR THE DETECTION OF UROLITHIASIS
#215CHROMATOGRAPHY DEVICE
#216Measurement of succinate in urine samples as a biomarker of kidney damage in diabetic subjects
#217Method for distinguishing between kidney dysfunctions
#218Method and device for monitoring medication usage
#219D/P CREATININE MARKER, METHOD OF DETERMINING D/P CREATININE, AND INTENDED USE THEREOF
#220Potentiometric biosensor for detection of creatinine and forming method thereof
#221Method of determing excretion of sodium and other analytes
#222Reference solution
#223Method of protein measurement
#224METHOD FOR MEASURING UREA
#225Dual type potentiometric creatinine biosensor
#226Ratiometric test strip and method
#227Test strip for determining concentration of creatinine in a body fluid sample
#228Luminescence-based recipe and device using the same
#229Modified sarcosine oxidase, process for producing the same and reagent composition using the same
#230Test strip for creatinine determination
#231Reference solution
#232Method and device for monitoring medication usage
#233Composition and method for detecting an adulterant in an aqueous sample